Advertisement
Canada markets close in 1 hour 23 minutes
  • S&P/TSX

    21,771.92
    +63.48 (+0.29%)
     
  • S&P 500

    4,968.77
    -42.35 (-0.85%)
     
  • DOW

    37,920.41
    +145.03 (+0.38%)
     
  • CAD/USD

    0.7271
    +0.0007 (+0.10%)
     
  • CRUDE OIL

    83.19
    +0.46 (+0.56%)
     
  • Bitcoin CAD

    88,525.64
    +2,154.05 (+2.49%)
     
  • CMC Crypto 200

    1,384.35
    +71.73 (+5.68%)
     
  • GOLD FUTURES

    2,410.40
    +12.40 (+0.52%)
     
  • RUSSELL 2000

    1,941.24
    -1.72 (-0.09%)
     
  • 10-Yr Bond

    4.6170
    -0.0300 (-0.65%)
     
  • NASDAQ

    15,302.07
    -299.43 (-1.92%)
     
  • VOLATILITY

    18.64
    +0.64 (+3.56%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

1 Green Flag and 1 Red Flag for Novavax

1 Green Flag and 1 Red Flag for Novavax

Novavax (NASDAQ: NVAX) has had more than its share of ups and downs over the past few years -- and investors have been along for the ride. The stock soared 2,700% in 2020 as the company brought its coronavirus vaccine candidate through late-stage clinical trials. The biotech company's vaccine reached commercialization later than rivals.